Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment-Reference-Cited by-同舟云学术

Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment

Published:2020-04-08 Issue:9 Volume:32 Page:1091-1098
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Bertani Lorenzo,Mumolo Maria Gloria,Tapete Gherardo,Albano Eleonora,Baiano Svizzero Giovanni,Zanzi Federico,Ceccarelli Linda,Bellini Massimo,Marchi Santino,Costa Francesco

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference90 articles.

1. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen.;Dale;Eur J Biochem,1983

2. Fecal calprotectin.;Rodrigo;Rev Esp Enferm Dig,2007

3. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.;Mao;Inflamm Bowel Dis,2012

4. From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting.;Mumolo;World J Gastroenterol,2018

5. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.;Poullis;Cancer Epidemiol Biomarkers Prev,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microcapsules based on biological macromolecules for intestinal health: A review;International Journal of Biological Macromolecules;2024-09

2. Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains;BMC Microbiology;2024-06-29

3. Diagnostic Accuracy of Fecal Calprotectin in Discriminating Organic-Inflammatory Gastrointestinal Diseases and Functional Gastrointestinal Disorders in Older Patients;Journal of Personalized Medicine;2024-02-21

4. Multimodal Ultrasound Technology Combined with Fecal Calprotectin Assessment in Clinical Studies of Inflammatory Bowel Disease;Advances in Clinical Medicine;2024

5. Today and tomorrow: the use of biomarkers in inflammatory bowel disease;Canadian IBD Today;2023-10-30